Generic Biosimilar Medicines Association

Making Medicines Affordable

  • Home
  • About GBMA
    • Contact us
    • GBMA Members
    • Guiding principles
    • Code of Practice
      • Code Complaint Committee
      • Historical Event Reporting
      • Annual Review
        • 2011
        • 2012
        • 2013
        • 2014
        • 2015
        • 2016
        • 2017
        • 2018
        • 2019
        • 2020
        • 2021
      • Lodging a complaint
    • Media Enquiries
    • Our Objectives
    • Links
  • Advocacy
    • New 5-year Strategic Agreement
    • Extended Strategic Agreement
    • Generic Medicines Working Group (GMWG)
    • Submissions
  • Generics
    • Facts and Fallacies
    • Key Figures on Generic Medicines
    • What is a Generic Medicine?
    • Bioequivalence Explained
  • Biosimilars
    • IGBA Global Biosimilars Week
    • GBMA Position on Biosimilars
      • Impact of Biosimilars
      • Switching
      • Pharmacy Substitution
      • Regulation
      • Awareness and Uptake
      • Naming
    • Key Figures on Biosimilars
  • Topics
    • IGBA
    • Price Disclosure
    • Intellectual Property
    • International Trade Agreements
  • News
    • News 2022
    • News 2021
    • News 2020
    • News 2019
    • News 2018
    • News 2017
    • News 2016
    • News 2015
    • News 2014
  • GBMA Education
  • COVID-19 Virus
    • COVID-19 Virus: The Facts
You are here: Home / New 5-year Strategic Agreement

New 5-year Strategic Agreement

The Generic and Biosimilar Medicines Association (GBMA), Australia’s peak body for affordable medicines, are pleased to announce, the signing of a new 5-year Strategic Agreement with the Australian Government, with patient access to medicines at the core of its objectives. View the press release here.

The GBMA and its members have always advocated for patient access to affordable medicines and highlighted the vulnerabilities in the global and local supply chains. This has especially come to the forefront in the current pandemic environment.

On behalf of all Australians, the GBMA has achieved much-needed reforms to secure medicine supplies for Australian patients.  The centrepiece of the new Agreement is a commitment from the affordable medicines industry to hold an agreed increased level of stock in country, to better protect patients against supply volatility.

The measures negotiated in this Agreement aim to ensure access to medicines, without disruption, providing healthcare professionals and patients with confidence that continuity of therapy will be preserved.  This, together with reforms aimed to drive further savings to the PBS, will also allow the generic and biosimilars industry to continue delivering the fiscal headroom required to help subsidise new and innovative treatments for Australian patients.

With the generic and biosimilar medicines industry contributing more than two thirds of all medicines listed on the PBS, GBMA members will continue to work with the Government and all industry stakeholders to protect Australians against medicine shortages and to ensure patients continue to have timely access to safe and affordable medicines.

At the heart of all our considerations are Australian patients and we are proud to partner with the Australian Government to maintain a world class health system.

GBMA signatories to the agreement at the virtual ceremony held on September 6, 2021, are Professor Jane Halton AO PSM, GBMA’s Independent Chair; Mr Dennis Bastas, GBMA Lead Negotiator and CEO and Chair, Arrotex Pharmaceuticals; and Ms Marnie Peterson, GBMA Chief Executive Officer.

For more information, please contact the GBMA – admin@gbma.com.au

Media Enquiries – Jannette Cotterell, Executive Counsel Australia – M  0419 204 059 – E  jcotterell@executivecounsel.com.au

Download image

 

Download image

 

Our Members

logo_ACCORD
logo_ACCORD
Organon logo
Organon logo
Juno
Juno
Sandoz logo
Sandoz logo
Viatris
Viatris
Arrow logo
Arrow logo
apotex
apotex
Celltrion Healthcare
Celltrion Healthcare
Fresnius Kabi
Fresnius Kabi
Fresnius Kabi
commercial_eyes
commercial_eyes
sinapse
sinapse

Generic Medicines: The Facts

Generic Medicines Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

Biosimilars

https://youtu.be/sBDur7xa084   Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Health Minister, Greg Hunt MP and Shadow Health Minister, Mark Butler MP both applaud the role of the GBMA Strategic Agreement for the security of the supply of vital medicines

April 1, 2022

Friday March 1, 2022 Canberra, ACT In one of his last speeches in Parliament as the … More...

Health Minister, Greg Hunt MP and Shadow Minister, Mark Butler MP confirmed as VIP speakers at the GBMA Industry Budget Week luncheon

March 15, 2022

Embargoed until Tuesday March 15, 2022 Canberra, … More...

Australia’s peak body for affordable medicines welcomes a new board member

February 15, 2022

Embargoed until Tuesday February 15, 2022 Canberra, … More…

© 2022 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us